SCHEMBL13717080

SCHEMBL13717080

O=C1/C(=N\O)Cc2ccc(Br)cc21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.59
CYP1A2 P05177 1/20 0.59
CYP2C19 P33261 1/20 0.59
TDP1 Q9NUW8 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
METAP1 P53582 1/20 0.45
S100A4 P26447 1/20 0.42
BCL2 P10415 1/20 0.41
MCL1 Q07820 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA4 P22748 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
TDP2 O95551 2/20 0.40
PARP1 P09874 1/20 0.40
PARP10 Q53GL7 1/20 0.40
MAOA P21397 3/20 0.39
MAOB P27338 3/20 0.39
CMA1 P23946 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3965520 1.00 ALDH1A1 (0.59) ALDH1A1CYP1A2CYP2C19TDP1L3MBTL1
SCHEMBL3965519 1.00 ALDH1A1 (0.59) ALDH1A1CYP1A2CYP2C19TDP1L3MBTL1
SCHEMBL3972234 0.90 ALDH1A1 (0.59) ALDH1A1CYP1A2CYP2C19TDP1L3MBTL1
SCHEMBL13716800 0.90 ALDH1A1 (0.59) ALDH1A1CYP1A2CYP2C19TDP1L3MBTL1
SCHEMBL3972232 0.90 ALDH1A1 (0.59) ALDH1A1CYP1A2CYP2C19TDP1L3MBTL1
SCHEMBL12797336 0.82 L3MBTL1 (0.51) ALDH1A1CYP1A2CYP2C19TDP1L3MBTL1
SCHEMBL1720607 0.79 ALDH1A1 (0.59) ALDH1A1CYP1A2CYP2C19METAP1CA1
SCHEMBL1719743 0.79 ALDH1A1 (0.59) ALDH1A1CYP1A2CYP2C19METAP1CA1
SCHEMBL17336561 0.79 ALDH1A1 (0.59) ALDH1A1CYP1A2CYP2C19METAP1TDP2
SCHEMBL1720606 0.79 ALDH1A1 (0.59) ALDH1A1CYP1A2CYP2C19METAP1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7572809-B2 Isoquinoline aminopyrazole derivatives HOFFMANN-LA ROCHE INC. (US) 2009-08-11 US disclosed
US-7572809-B2 Isoquinoline aminopyrazole derivatives HOFFMANN-LA ROCHE INC. (US) 2009-08-11 US disclosed
US-20070179151-A1 Isoquinoline aminopyrazole derivatives F. HOFMANN-LA ROCHE AG (CH) 2007-08-02 US disclosed
US-20070179151-A1 Isoquinoline aminopyrazole derivatives F. HOFMANN-LA ROCHE AG (CH) 2007-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070179151-A1 Isoquinoline aminopyrazole derivatives CYP3A5, CYP3A43, CYP3A4 ALDH1A1 198/4885CYP1A2 9/4885CYP2C19 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.